Ignite Creation Date:
2025-12-24 @ 6:56 PM
Ignite Modification Date:
2026-01-24 @ 6:02 PM
Study NCT ID:
NCT03284957
Status:
TERMINATED
Last Update Posted:
2025-11-24
First Post:
2017-09-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase 1/2 Study of Amcenestrant (SAR439859) Single Agent and in Combination With Other Anti-cancer Therapies in Postmenopausal Women With Estrogen Receptor Positive Advanced Breast Cancer
Sponsor:
Sanofi
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-09-20
Start Date Type:
ACTUAL
Primary Completion Date:
2024-11-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-11-08
Completion Date Type:
ACTUAL
First Submit Date:
2017-09-13
First Submit QC Date:
None
Study First Post Date:
2017-09-15
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-11-06
Results First Submit QC Date:
None
Results First Post Date:
2025-11-24
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-06
Last Update Post Date:
2025-11-24
Last Update Post Date Type:
ESTIMATED